Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights
14 févr. 2023 08h14 HE
|
Intelligent Bio Solutions, Inc.
- Second quarter total revenue and government support income increased over 100% year-over-year - - Government support income increased 52% for the quarter ended December 31, 2022 compared to the...
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
09 févr. 2023 12h15 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a life sciences company developing and delivering...
Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing
07 févr. 2023 07h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that Boughey Distribution (“Boughey”), one of the United Kingdom’s leading...
Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests
31 janv. 2023 08h31 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that global garden equipment manufacturer Hozelock will implement drug...
Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development
23 janv. 2023 07h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering...
Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering
22 déc. 2022 17h02 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing non-invasive, real-time diagnostic testing for patients...
Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders
21 déc. 2022 16h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that its Board of Directors has cancelled the Company’s annual meeting of...
Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights
09 nov. 2022 16h05 HE
|
Intelligent Bio Solutions, Inc.
- Acquired Intelligent Fingerprinting Limited and its proprietary drugs of abuse screening technology - - Announced new additions to Board of Directors and name change to Intelligent Bio Solutions...
Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations
07 nov. 2022 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company developing non-invasive, real-time diagnostic testing for patients...
Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing
03 nov. 2022 08h30 HE
|
Intelligent Bio Solutions, Inc.
- Eastern Airways to use portable, hygienic, non-invasive fingerprint sweat test to support new European Aviation Authority regulations - NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio...